3BORGER M A,CARSON S M,IVANOV J,et al.Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up:a large retrospective study[J].Ann Thorac Surg,2005,80(6):1610-1614.
4VYAVAHARE N R,CHEN W,JOSHI R R,et al.Current progress in anticalcification for bioprosthetic and polymeric heart valve[J].Cardiovasc Pathol,1997,6(4):219-229.
5SHANTHI C,PANDURANGA R K.Regulation of biocalcification of bovinepericardial tissue by grafting poly (glycidyl methacrylatebutylacry-late) copolymers[J].J Bioact Compat Polym,1997,12(4):308-320.
8REISNER S A,MELTZERR R S,ROCHESTER N Y,et al.Normal values of prosthetic valve Doppler echocardiographic parameters:a review[J].J Am Soc Echo,1998(3):201-210.
10GENONI M,FRANZEN D,VOGT P,et al.Paravalvular leakage after mitral valve replacement:improved long-term survival with aggressive surgery[J]? Eur J Cardiothorac Surg,2000,17:14-19.
二级参考文献33
1Edmunds LH, Clark RE, Cohn LH, etal. Guiddines far mmbidity and mortality after cardiac valvular operation. J Thorac Cardiovaac Surg, 1996,112:708-711.
2Jamieson WR, Edwards FH, Bern JW, et al. Pisk straatificatian for cardiac valve replacement. National Cardiac Surgery Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg, 1999, 67:943-951.
3Flameng WJ, Herijgers P, Szcsi J, et al. Determinants of early and late resuits of combined valve operations and coronary eatery bypess grafting. Ann Thorac Surg, 1996,61:621 - 628.
4Karp RB, Mills N, Edmunds LH Jr.Coronary artery bypase garfting in the presence of valvular disease. Circulation, 1989,79(6 Pt 2):1182-184.
5van Herwarden LA, Tjan D, Tjissen JG, et al. Determinants of survival after surgery for mitral valve regurgitation in patients with and without coronary artery disease.Eur J Cardiothorac Surg,1990,4:329-335.
6Czer LS, Gray RJ, Stewart ME, eta]. Reduction in sudden late death by concomitant revascularization with acrtic valve replacement, J Thorac Cardiovasc Surg, 1988,95:390-401.
7Magovern JA,Pennock JL,Campbell DB,et al. Aortic valve replacement and combined aortic valve replacement and coronary artery bypess grafting:predicting high risk groups,J Am Coll Cardiol, 1987,9:38-43.
8Loisance DY, Mazzucotelli JP, Bertrand PC, et al. Mitroflow periesrdial valve: long-term durability. Ann Thorac Surg, 1993,56:131 - 136.
9Murakami T, Eishi K, Nakano S, et al. Aortic and nitral valve replacement with the Carpentier-Edwards pericardial bioprosthsis:10-year results, J Heart Valve Dis, 1996,5:45-49.
10Zhu XD, Gou JQ, Chert YC, et al. Ten-year experience with pericantial xenograft valves. J Thorac Cardiovaac Surg, 1988,95:572- 576.
1Zhang Jianyu . The Impact of FGF23and Klotho Protein on Se- nile Degenerative Heart Valvular Disease and Related Risk Fac- tors Analysis [J]. Southern Medical University, 2014:89-92.
2Zhang Ben. Experiment Study of Transcatheter Polymeric Pros- thetic Heart Valve Based on Ultramicroporous Expanded Polytetrafluoroethylene [D] . Second Military Medical Universi- ty, 2014:15-19.
3Luo Wanjun. Effects of Remote Ischemic Perconditioning on Or- gans Protection in Adult Valve Replacement [D]. Central South University, 2014 .. 103-106.
